Fortress Biotech
FBIO
#10130
Rank
A$97.83 M
Marketcap
A$2.93
Share price
-0.49%
Change (1 day)
-36.67%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): A$0.21 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are A$68.46 Million. In 2025 the company made an earning of -A$48.47 Million, an increase over its 2024 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.21 B-535.47%
2025 -A$48.47 Million-72.02%
2024 -A$0.18 Billion-21.6%
2023 -A$0.23 Billion-28.03%
2022 -A$0.31 Billion29.88%
2021 -A$0.24 Billion59.8%
2020 -A$0.15 Billion1.17%
2019 -A$0.15 Billion-19.84%
2018 -A$0.19 Billion28.99%
2017 -A$0.15 Billion37.92%
2016 -A$0.11 Billion32.31%
2015 -A$77.49 Million164.31%
2014 -A$29.32 Million-45.14%
2013 -A$53.44 Million37.55%
2012 -A$38.85 Million-22.91%
2011 -A$50.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
A$0.16 B-20.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-180.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-A$48.93 Million-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-A$48.74 Million-123.23%๐Ÿ‡บ๐Ÿ‡ธ USA